ADVOCATING FOR AUSTRALIAN CHILDREN LIVING WITH VISION IMPAIRMENT
Australian Childhood Vision Impairment Register
With
Dr Susan Silveira
Chief Investigator
Australian Childhood Vision Impairment Register, NextSense &
Program Director
Master of Disability Studies (Macquarie University), NextSense
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Sydney | June 2025
The Australian Childhood Vision Impairment Register (ACVIR), the first of its kind in Australia, captures uniquely Australian data which is used to improve services for children with vision impairment. The data is also available to researchers who work in the area of eye disease and disorders of vision.
Currently in Australia, we don’t know how many Australian children have vision impairment.
This makes it hard to plan for the services these children need, or to argue for research into preventing conditions which cause vision impairment.
NextSense Institute, in partnership with key Australian service providers, corporate donors, government departments and health professionals, has undertaken a major research project to develop and maintain an Australia-wide record of children with vision impairment.
This project is called the Australian Childhood Vision Impairment Register.
Australian Health Journal spoke with Dr Susan Silveira, Chief Investigator of the Register.
The Register collects accurate information on children who have been diagnosed by an ophthalmologist (eye doctor) with vision impairment.. This information is used to establish the number of children with vision impairment, the causes and level of vision impairment and any additional disabilities and health conditions these children have.
The Parent or guardian of a child, aged 0-18 years, who has been diagnosed by an ophthalmologist with vision impairment, are invited to join the Australian Childhood Vision Impairment Register.
The Australian Childhood Vision Impairment Register (ACVIR) is sponsored by NextSense with support from Guide Dogs, Vision Australia, low vision service providers and families of children with vision loss.
Source: Written by AUDIENCED sourced from NextSense website
-
Mission to raise awareness of sarcoma and need for clinical trial funding
Sarcoma, a rare and aggressive cancer, remains the deadliest cancer for children and young adults, accounting for nearly one third (30%) of cancer-related deaths among those aged 15–24 and one tenth (10%) of those aged 0–14. Further, still severely under-diagnosed, sarcoma only accounts for one sixth (15%) of all cancer diagnoses in the 15 – 24 age group, and less than a tenth (8%) among children under 10.
-
Orthopaedic surgeon driven to understand & manage infection
In tandem with his clinical practice, Associate Professor Tetsworth is deeply engaged in orthopaedic research, with a keen interest in infection management, infection control, limb salvage, bone defect reconstruction, biomarker development for infection, bone growth hormone delivery, and the use of 3D printed models for reconstructing segmental bone defects.
-
Study on digital tool for pharmacists in aged care
In March 2022, the Australia government announced $350 million of funding over 4 years to employ on-site pharmacists in residential aged care, starting July 2023. In April 2023, the government made changes to the proposed on-site pharmacists, where the new program will now be delivered by and through community pharmacies. Regardless of how the model will be implemented, the goal remains the same – to improve quality use of medicines and medicines safety for aged care residents.
